<DOC>
	<DOC>NCT00029523</DOC>
	<brief_summary>The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.</brief_summary>
	<brief_title>DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningeal Carcinomatosis</mesh_term>
	<mesh_term>Meningeal Neoplasms</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Diagnosed (or previously diagnosed) with lymphoma or a solid tumor (not leukemia) Diagnosed with neoplastic meningitis If female, not pregnant and will not become pregnant while onstudy No other experimental therapy within 21 days of participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>neoplastic</keyword>
	<keyword>meningitis</keyword>
	<keyword>cerebrospinal fluid</keyword>
	<keyword>CSF</keyword>
	<keyword>meningeal</keyword>
	<keyword>meninges</keyword>
	<keyword>CNS</keyword>
	<keyword>Leptomeningeal Neoplasms</keyword>
</DOC>